# ASTRUM-005 (NCT04063163)

> A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04063163
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Shanghai Henlius Biotech
- Conditions: Extensive Stage Small Cell Lung Cancer
- Interventions: HLX10; carboplatin and etoposide; placebo
- Enrollment: 585
- Primary outcome: OS

## Indexed commentary on ASTRUM-005 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 11
- Podcasts: 2
- YouTube: 1

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=astrum-005-nct04063163

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04063163", "email": "<work email>"}; the inbox owner confirms by the emailed link.